← Scroll for more →
Gain Therapeutics, Inc. (GANX)
Pharmaceutical Preparations
Latest Price
$1.73
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.26
P/B Ratio
6.54
Institutional Ownership
19.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 1.92M | $3.0M | 4.44% | +153.8K | 2026-06-30 |
| Potomac Capital Management, Inc. | 946.4K | $1.0M | 2.18% | -62.2K | 2026-06-30 |
| Gsa Capital Partners LLP | 632.1K | $1.0M | 1.46% | +319.7K | 2026-06-30 |
| Jones Financial Companies Lllp | 608.6K | $1.0M | 1.40% | -23.0K | 2026-06-30 |
| Cambridge Investment Research Advisors, Inc. | 568.6K | $1.0M | 1.31% | -- | 2026-06-30 |
| DME Capital Management, LP | 566.1K | $1.0M | 1.31% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 480.3K | -- | 1.11% | +80.4K | 2026-06-30 |
| Geode Capital Management, LLC | 453.5K | -- | 1.05% | +6.2K | 2026-06-30 |
| BlackRock, Inc. | 275.0K | -- | 0.63% | +49.9K | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 231.5K | -- | 0.53% | +1.6K | 2026-06-30 |